Invention Grant
- Patent Title: Compositions and methods for treatment of SARS-COV-2
-
Application No.: US18160950Application Date: 2023-01-27
-
Publication No.: US11986516B2Publication Date: 2024-05-21
- Inventor: Michelle Lorraine Rivera
- Applicant: Phenom Pharmaceuticals, LLC
- Applicant Address: US FL Miami Beach
- Assignee: Phenom Pharmaceuticals, LLC
- Current Assignee: Phenom Pharmaceuticals, LLC
- Current Assignee Address: US FL Miami Beach
- Agency: Fish & Richardson P.C.
- Main IPC: A61K38/48
- IPC: A61K38/48 ; A61K47/10 ; A61K47/12 ; A61K47/26 ; A61K47/38 ; A61P31/14
Abstract:
Disclosed herein are formulations comprising recombinant human angiotensin converting enzyme 2 (rhACE-2) and a cellulose derivative for the prevention and treatment of a coronavirus infection. Methods and kits are also provided herein.
Public/Granted literature
- US20230302101A1 COMPOSITIONS AND METHODS FOR TREATMENT OF SARS-COV-2 Public/Granted day:2023-09-28
Information query
IPC分类:
